CompletedNot Applicable

Evaluation of Auto Antibodies in Oral Sub Mucous Fibrosis

India70 participantsStarted 2015-01

Plain-language summary

The etiology of OSMF is considered to be multifactorial. However, Role of autoimmunity had been suggested as one of the factors but remains unproven. The present study is undertaken to evaluate the presence of auto antibodies in OSMF patients to pave a way for new arena of treatment with the etiology of this persistent condition

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients who are willing for the study. * A positive history of chewing arecanut, and/or smoking tobacco and alcohol. * Patients with clinical and histopathological features of oral submucous fibrosis. * Patients with OSMF not under any treatment for the same Exclusion Criteria: * Unwilling patients who do not want to be part of the study. * Patients with known autoimmune disorders.

What they're measuring

Evaluation of auto antibodies in oral sub mucous fibrosis

Timeframe: one and half year

Trial details

NCT IDNCT03011086

SponsorPanineeya Mahavidyalaya Institute of Dental Sciences & Research Centre

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2017-11

View on ClinicalTrials.gov More Oral Submucous Fibrosis trials